Urine Bacteriology in Post-Kidney Transplant Patients with Double-J Stents
DOI:
https://doi.org/10.30442/ahr.0704-04-146Keywords:
Bacterial colonisation, End-Stage Renal Disease, DOuble-J, Ureteric Stenting, Urinary Tract InfectionAbstract
Background: Kidney transplantation is the gold standard treatment modality for patients with end-stage renal disease. Ureteric stenting is commonly used during kidney transplantation to reduce the incidence of ureteric complications post-transplantation. The presence of ureteric stents could be complicated by bacterial colonisation and urinary tract infections.
Objective: To identify the urinary flora in patients with double-J stents following kidney transplantation and establish bacteria colonisation and their antimicrobial susceptibility.
Methods: Over one-year, single urine samples of consecutive 100 post-renal transplant patients were subjected to bacteriologic analysis. Early morning midstream urine was obtained into a sterile bottle from all the participants for laboratory analysis.
Results: The mean age of post kidney transplantation patients was 47.6 ±12.3 years. Hypertension and diabetes were the commonest co-morbidities associated with End-Stage-Renal-Disease (ESRD), accounting for 61% and 28%, respectively. E. coli was the commonest isolate (70.4%). Microbiological evidence of Urinary Tract Infection (UTI) revealed by pyuria (pus cells >4/HPF) was found in 40.9%. Tigecycline, nitrofurantoin and tetracycline showed the highest sensitivity pattern in 9%, 8% and 8%, respectively, with significant resistance against cephalosporins and fluoroquinolones.
Conclusion: The fourth week of double-J ureteric stent insertion in kidney transplant recipients showed a high incidence of urinary bacterial colonisation.
References
Garcia GG, harden P, Chapman J. the global role of kidney transplantation. Am J Nephrol 2012; 35: 259-264. https://doi.org/10.5812/nephropathol.7448
Salako AA, Badmus TA, Igbokwe MC, David RA, Laoye A, Akinbola IA, et al. Experience with arteriovenous fistula creation for maintenance hemodialysis in a tertiary hospital in South-western Nigeria. Saudi J Kidney Dis Transpl 2018; 29: 924-929. https://doi.org/10.4103/1319-2442.239628
Jha V. Current status of end-stage renal disease care in South Asia. Ethn Dis 2009; 19; 27-32.
Dulal RK, Karki S. Nepalese kidney transplant recipient in a follow-up clinic: related and unrelated living donor. J Nepal Med Assoc 2008; 47: 98-103.
Enns J, Aryal G. A path to renal transplantation in Nepal. J Pathol Nepal 2011; 1: 52-55.
Veroux M, Giuffrida G, Corona D, Gagliano M, Scriffignano V, Vizcarra D. Infective complications in renal allograft recipients: Epidemiology and outcome. Transplantation Proc 2008; 40: 1873-1876. https://doi.org/10.1016/j.transproceed.2008.05.065
Golębiewska J, Dębska-Ślizień A, Komarnicka J, Samet A, Rutkowski B. urinary tract infections in renal transplant recipients. Transplantation Proc 2011; 43: 2985-2990. https://doi.org/10.1016/j.transproceed.2022.07.010
Shohab D, Khawaja A, Atif E, Jamil I, Ali I, Akhter S. Frequency of occurrence of urinary tract infection in double J stented versus non-stented renal transplant recipients. Saudi J Kidney Dis Transpl 2015; 26: 443-446. https://doi.org/10.4103/1319-2442.157298
Kirnap M, Boyvat F, Torgay A, Moray G, Yildirim S, Haberal M. Incidence of urinary complications with Double J Stents in Kidney Transplantation. Exp Clin Transplant 2019; 1: 148-152. https://doi.org/10.6002/ect.MESOT2018.P14
Indu KN, Lakshminarayana G, Anil M. Is early removal of prophylactic ureteric stents beneficial in live donor renal transplantation? Indian J Nephrol 2012; 22: 275-279. https://doi.org/10.4103/0971-4065.101247
Shabeena KS, Bhargava R, Manzoor MAP, Mujeeburahiman M. Characteristics of bacterial colonisation after indwelling double-J ureteral stents for different time duration. Urol Ann 2018; 10: 71-75. https://doi.org/10.4103/UA.UA_158_17
Igbokwe MC, Abu S, Aremu A, Olatise O, Okafor M. Spectrum of Endo-urological procedures performed at a Nigerian Kidney Transplant Centre. Yenagoa Med J 2020; 2: 1-6.
Igbokwe M. Experience and early outcomes of Kidney Transplantation in a Nigerian Transplant in a Nigerian Transplant Institution: A 1-Year Review. 40th Congress of the Societe Internationale D’Urologie; montreal, Canada: SIU Academy; 2020. pSP-18.02. https://doi.org/10.13140/RG.2.2.30933.14562
Tavakoli A, Surange RS, Pearson RC, Parrott NR, Augustine T, Riad HN. Impact of stents on urological complications and health care expenditure in renal transplant recipients: Results of a prospective, randomised clinical trial. J Urol 2007; 177: 2260-2264. https://doi.org/10.1016/j.juro.2007.01.152
Arogundade FA. Kidney transplantation in a low-resource setting: Nigeria Experience. Kidney Int Suppl 2013; 3: 241-245. https://doi.org/10.1038/kisup.2013.23
Ulasi II, Ijoma CK. The enormity of chronic kidney disease in Nigeria: the situation in a teaching hospital in southeast Nigeria. J Trop Med 2010; 2010.501957. https://doi.org/10.1155/2010/501957
Joshi R, Singh DR, Sharma S. Lower urinary tract infection and bacterial colonisation in patients with Double-J ureteral stent. J Nepal Health Res Counc 2011; 9: 165-168.
Kehinde EO, Rotimi VO, Al-Hunayan A. Bacteriology of urinary tract infection associated with indwelling J ureteral stents. J Endourol 2004; 18: 891-896. https://doi.org/10.1089/end.2004.18.891
Kozyrakis D, Perikleous S, Chatzistamou Z-E, Kateris D, Soukias G, Karatzas A, et al. Is there a role for Double J stent culture in contemporary urology? Urol Int 2018; 100: 203-208. https://doi.org/10.1159/000486798
Nzalie RN-t, Gonsu HK, Koulla-Shiro S. Bacterial etiology and antibiotic resistance profile of community-acquired urinary tract infections in a Cameroonian city. Int J Microbiol 2016; 2016: 3240268. https://doi.org/10.1155/2016/3240268
Ahmed SS, Shariq A, Alsalloom AA, Babikir IH, Alhoumoud BN. Uropathogens and their antimicrobial resistance patterns: Relationship with urinary tract infections. Int J Health Sci 2019; 13: 48-55.
Downloads
Published
Issue
Section
License
The articles and other materials published in the Annals of Health Research are protected by the Nigerian Copyright laws. The journal owns the copyright over every article, scientific and intellectual materials published in it. However, the journal grants all authors, users and researchers access to the materials published in the journal with the permission to copy, use and distribute the materials contained therein only for academic, scientific and non-commercial purposes.